ERBB2 and breast carcinoma: We show that carbonic anhydrases (a) elevate pH in breast carcinomas by accelerating net H+ elimination from cancer cells and across the interstitial space, (b) raise immune infiltration and inflammation and decelerate growth of ErbB2-induced breast carcinomas, and (c) improve survival specifically for patients with HER2-enriched breast cancer.